Significance, reliability, and interpretation of developmental and reproductive toxicity study findings

Developmental and Reproductive Toxicology: A Practical Approach

Volumn , Issue , 2005, Pages 329-424

  Holson, Joseph F ^a   Nemec, Mark D ^a   Stump, Donald G ^a   Kaufman, Lewis E ^a   Lindström, Pia ^b   Varsho, Bennett J ^a  

^a WIL RESEARCH LABORATORIES   (United States)

^b Maxim Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85123816417     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (176)

1. DeSesso, J.M., Harris, S.B., and Swain, S.M., The design, evaluation, and interpretation of developmental toxicity tests, in Toxicology and Risk Assessment: Principles, Methods, and Applications, Fan, A.M. and Chang, L.W., Eds., Marcel Dekker, New York, 1996, p. 227.
2. Palmer, A.K. and Ulbrich, B., Data presentation in developmental toxicity studies: an aid to evaluation? in Handbook of Developmental Toxicology, Hood. R.D., Ed., CRC Press, Boca Raton, FL, 1997, chap. 8.
3. Daston, G. and Kimmel, C.A., Eds., An Evaluation and Interpretation of Reproductive Endpoints for Human Health Risk Assessment, International Life Sciences Institute, Washington, DC,1998.
4. European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC), Guidance on Evaluation of Reproductive Toxicity Data, Monograph No. 31, 2002.
5. U.S. Food and Drug Administration, Reviewer Guidance: Integration of Study Results to Assess Concerns about Human Reproductive and Developmental Toxicities (Draft), Center for Drug Evaluation and Research, 2001.
6. Wilson, J.G., Environment and Birth Defects, Academic Press, New York, 1973.
7. Brent, R.L., Drug testing for teratogenicity: its implications, limitations and application to man, in Drugs and Fetal Development, Klingberg, M.A., Abramovici, A., and Cheneke, J., Eds., Plenum Press, New York, 1972, p. 31.
8. Nishimura, H. and Tanimura, T, Chemical Aspects of the Teratogenicity of Drugs, Elsevier, New York, 1976.
9. Fraser, F.C., Relation of animal studies to the problem in man, in Handbook of Teratology, Vol. 1, Wilson, J.G. and Fraser, F.C., Eds., Plenum Press, New York, 1979, p. 75.
10. Snow, M.H.L. and Tam, P.P.L., Is compensatory growth a complicating factor in mouse teratology?, Nature, 279, 555, 1979.
11. U.S. Food and Drug Administration, National Center for Toxicological Research, Reliability of Experimental Studies for Predicting Hazards to Human Development (Kimmel, C.A., Holson, J.F., Hogue, C.I., and Carlo, G.L., Eds.), NCTR Technical Report for Experiment No. 6015, Jefferson, AR, 1984.
12. National Research Council, Scientific Frontiers in Developmental Toxicology and Risk Assessment, National Academy Press, Washington, DC, 2000.
13. Ulbrich, B. and Palmer, A.K., Detection of effects on male reproduction - a literature survey, J. Am. Coll. Toxicol., 14, 293, 1995.
14. Clegg, J.A., Adverse drug reactions, Toxicol. Rev., 13, 235, 1994.
15. Buiatti, E, Barchielli, A., Geddes, M., Nastasi, L., Kriebel, D., Franchini, M., and Scarselli, G., Risk factors in male infertility, Arch. Environ. Health, 39, 266, 1984.
16. Paul, M. and Himmelstein J., Reproductive hazards in the workplace: what the practitioner needs to know about chemical exposures, Obstet. Gynecol., 71, 921, 1988.
17. Thomas, M.J. and Thomas, J.A., Toxic responses of the reproductive system, in Casarett & Doull's Toxicology, the Basic Science of Poisons, Klassen, C.D., Ed., McGraw-Hill, New York, 2001, p. 673.
18. Waller, D.P., Killinger, J.M., Zaneveld, L.J.D., Physiology and toxicology of the male reproductive tract, in Endocrine Toxicology, Thomas, J.A., Korach, K.S., and McLachlan, J.A., Eds., Raven, New York, 1985, p. 269.
19. Scialli, A.R. and Lemasters, G.K., Epidemiologic aspects of reproductive toxicology, in Reproductive Toxicology, 2nd ed., Witorsch, R.J., Ed., Raven Press, 1995, p. 241.
20. Potashnik, G. and Porath, A., Dibromochloropropane (DBCP): a 17-year reassessment of testicular function and reproductive performance, J. Occup. Environ. Med., 37, 1287, 1995.
21. Goldsmith, J.R., Dibromochloropropane: epidemiological findings and current questions, Ann. N. Y. Acad. Sci., 26, 837, 1997.
22. Meistrich, M.L., Wilson, G., Shuttlesworth, G.A., and Porter, K.L., Dibromochloropropane inhibits spermatogonial development in rats, Reprod. Toxicol., 17, 263, 2003.
23. Cooper, R.L., Neuroendocrine control of female reproduction, in Reproductive and Endocrine Toxicology (Comprehensive Toxicology, Vol. 10), Boekelheide, K., Chapin, R.E., Hoyer, P.B., and Harris, C., Eds., Elsevier, New York, 1997, p. 273.
24. Eldridge, J.C., Wetzel, L.T., Stevens, J.T., and Simpkins, J.W., The mammary tumor response in triazine-treated female rats: a threshold-mediated interaction with strain and species-specific reproductive senescence, Steroids, 64, 672, 1999.
25. Cooper, R.L., Goldman, J.M., and Rehnberg, G.L., Neuroendocrine control of reproductive function in the aging female rodent, J. Am. Geriatric Sci., 34, 735, 1986.
26. Cooper, R.L., Stoker, T.E., Goldman, J.M., Parrish, M.B., and Tyrey, L., Effect of atrazine on ovarian function in the rat, Reprod. Toxicol., 10(4), 257, 1996.
27. U.S. Food and Drug Administration, Guidelines for Reproduction Studies for Safety Evaluation of Drugs for Human Use, 1966.
28. U.S. Federal Food and Drugs Act of 1906, Public Law No. 59-384, 34 Stat. 768, 1906.
29. U.S. Federal Food, Drug and Cosmetic Act, 21 U.S.C. 301, 1938.
30. Green, R., Burrill, M., and Ivy, A., Experimental intersexuality: the paradoxical effects of estrogens on the sexual development of the female rat, Anat. Rec., 74, 429, 1939.
31. Green, R., Burrill, M., and Ivy, A., Experimental intersexuality: modification of sexual development of the white rat with synthetic estrogen, Proc. Soc. Exp. Biol. Med., 41, 169, 1939.
32. Herbst, A.L., Ulfelder, H., and Poskanzer, D.C., Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women, N. Eng. J. Med., 284, 878, 1971.
33. Herbst, A.L., Cole, P., Colton, T., Robboy, S.J., and Scully, R.E., Age-incidence and risk of diethyl-stilbestrol-related clear cell adenocarcinoma of the vagina and cervix, Am. J. Obstet. Gynecol., 128, 43, 1977.
34. Lehman, A.J., Laug, E.P., Woodard, G., Draize, J.H., Fitzhugh, O.G., and Nelson, A.A., Procedures for the appraisal of the toxicity of chemicals in foods, Food Drug Cosmetic Law Quarterly, September, 1949.
35. Mauer, I., Ed., Appraisal of the Safety of Chemicals in Foods, Drugs and Cosmetics, The Association of Food and Drug Officials of the United States, Washington, D.C., 1959.
36. Hendrickx, A.G. and Binkerd, P.E., Nonhuman primates and teratological research, J. Med. Primatol., 19, 81, 1990.
37. Buelke-Sam, J., Kimmel, C.A., Adams, J., Nelson, C.J., Vorhees, C.V., Wright, D.C., Omer, V. St., Korol, B.A., Butcher, R.E., Geyer, M.A., Holson, J.F., Kutscher, C.L., and Wayner, M.J., Collaborative behavioral teratology study: results, Neurotoxicol. Teratol., 7, 591, 1985.
38. U.S. Environmental Protection Agency, Office of Pesticide Programs. Proposed guidelines for registering pesticides in the United States; Hazard evaluation: Humans and domestic animals, Fed. Regist., 43, 37336, 1978.
39. U.S. Environmental Protection Agency, Guidelines for developmental toxicity risk assessment; notice, Fed Regist., 56, 63798, 1991.
40. U.S. Environmental Protection Agency, Reproductive toxicity risk assessment guidelines; notice, Fed. Regist., 61, 56274, 1996.
41. Eaton, D.L. and Klaassen, C.D., Principles of toxicology, in Casarett & Doull's Toxicology: The Basic Science of Poisons, 6th ed., Klaassen, C.D., Ed., McGraw-Hill, New York, 2001, p. 11.
42. vom Saal, F.S., Timms, B.G., Montano, M.M., Palanza, P., Thayer, K.A., Nagel, S.C., Dhar, M.D., Ganjam, V.K., Parmigiani, S., and Welshons, W.V., Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses, Proc. Natl. Acad. Sci. USA, 94, 2056, 1997.
43. Shuey, D.L., Lau, C., Logsdon, T.R., Zucker, R.M., Elstein, K.H., Narotsky, M.G., Setxer, R.W., Kavlock, R.J., and Rogers, J.M., Biologically-based dose-response modeling in developmental toxicology: biochemical and cellular sequelae of 5-fluorouracil exposure in the developing rat, Toxicol. Appl Pharmacol., 126, 129, 1994.
44. Young, J.F. and Holson, J.F., Utility of pharmacokinetics in designing toxicological protocols and improving interspecies extrapolation, J. Environ. Pathol. Toxicol., 2, 169, 1978.
45. Scott, Jr. W.J. Collins, M.D., and Nau, H., Pharmacokinetic determinants of embryotoxicity in rats associated with organic acids, Environ. Health Perspect., 102(Suppl. 11), 97, 1994.
46. Faustman, E.M., Allen, B.C., Kavlock, R.J., and Kimmel, C.A., Dose-response assessment for developmental toxicity. I. Characterization of database and determination of no observed adverse effect levels, Fundam. Appl. Toxicol., 23, 478, 1994.
47. Hood, R.D., Effects of sodium arsenite on fetal development, Bull. Environ. Contam. Toxicol., 7, 216, 1972.
48. DeSesso, J.M., Jacobson, C.F., Scialli, A.R., Farr, C.H., and Holson, J.F., An assessment of the developmental toxicity of inorganic arsenic, Reprod. Toxicol., 12, 385, 1998.
49. Holson, J.F., Stump, D.G., Clevidence, K.J., Knapp, J.F., and Farr, C.H., Evaluation of the prenatal developmental toxicity of orally administered arsenic trioxide in rats, Food Chem. Toxicol., 38, 459, 2000.
50. Stump, D.G., Holson, J.F., Fleeman, T.L., Nemec, M.D., and Farr, C.H., Comparative effects of single intraperitoneal or oral doses of sodium arsenate or arsenic trioxide during in utero development, Teratology, 60, 283, 1999.
51. National Academy of Sciences, Sample size determination, in Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral Research, National Academies Press, Washington, DC, 2003, p. 176, Appendix A.
52. Nelson, C.J. and Holson, J.F., Statistical analysis of teratologic data: problems and advancements, J. Environ. Pathol. Toxicol., 2, 187, 1978.
53. Steel, R.G.D. and Torrie, J.H., Principles and Procedures of Statistics, A Biometrical Approach, 2nd ed., McGraw, New York, 1980, pp. 504-506.
54. Dunnett, C.W., New tables for multiple comparisons with a control, Biometrics, 20, 482, 1964.
55. Kruskal, W.H. and Wallis, W.A., Use of ranks in one-criterion variance analysis, J. Am. Statistical Assoc., 47, 583, 1952.
56. Holson, J.F., Scott, W.J., Gaylor, D.W., and Wilson, J.G., Reduced interlitter variability in rats resulting from a restricted mating period, and reassessment of the "litter effect", Teratology, 14, 135, 1976.
57. Holson, J.F., Gaines, T.B., Nelson, C.J., LaBorde, J.B., Gaylor, D.W., Sheehan, D.M., and Young, J.F., Developmental toxicity of 2,4,5-trichlorophenoxyacetic acid (2,4,5-T). I. Multireplicated dose-response studies in four inbred strains and one outbred stock of mice, Fundam. Appl. Toxicol., 19, 286, 1992.
58. Brown, N.A., Spielmann, H., Bechter, R., Flint, O.P., Freeman, S.J., Jelinek, R.J., Koch, E., Nau, H., Newall, D.R., Palmer, A.K., Renault, J.Y., Repetto, M.F., Vogel, R., and Wiger, R., Screening chemicals for reproductive toxicity: the current alternatives; the report and recommendations of an ECVAM/ETS workshop (ECVAM workshop 12), Altern. Lab. Anim., 23, 868, 1995.
59. Chapin, R.E. and Sloane, R.A., Reproductive assessment by continuous breeding: evolving study design and summaries of ninety studies, Environ. Health Persp., 105(Suppl. 1), 199, 1997.
60. Gesellschaft Deutscher Chemiker (GDCh - German Chemical Society), Evaluation of OECD Screening Tests 421 (Reproduction/Developmental Toxicity Screening Test) and 422 (Combined Repeated Dose Toxicity Study with the Reproduction/Developmental Toxicity Screening Test), edited by the GDCh Advisory Committee on Existing Chemicals (BUA), BUA Report 229, S. Hirzel Wissenschaftliche Verlagsgesellschaft, Stuttgart, 2002.
61. Hurtt, M.E., Cappon, G.D., and Browning, A., Proposal for a tiered approach to developmental toxicity testing for veterinary pharmaceutical products for food-producing animals, Food Chem. Toxicol., 41, 611, 2003.
62. Stump, D.G., Holson, J.F., Pearce, L.B., Rentko, V.T., and Gawryl, M.S., Finding of developmental toxicity studies of HBOC-201 in rodent and canine models [abstract], Birth Defects Res. (Part B), 68, 250, 2003.
63. Holson, J.F., Pearce, L.B., and Stump, D.G., A probable false positive finding of prenatal toxicity in the rodent model with a high molecular weight protein oxygen therapeutic: evidence and implications [abstract], Birth Defects Res. (Part B), 68, 249, 2003.
64. Fraser, F.C., The multifactorial/threshold concept - use and misuses, Teratology, 14, 267, 1976.
65. Adolph, E.F., Ontogeny of physiological regulations in the rat, Quart. Rev. Biol., 32, 89, 1957.
66. Gibson, K.J. and Lumbers, E.R., Mechanisms by which the pregnant ewe can sustain increased salt and water supply to the fetus, J. Physiol., 445, 569, 1992.
67. Gibson, K.J. and Lumbers, E.R., The roles of arginine vasopressin in fetal sodium balance and as a mediator of the effects of fetal "stress," J. Develop. Physiol., 19, 125, 1993.
68. Torchinsky, A., Fein, A., and Toder, V., Modulation of embryo sensitivity to teratogen by nonspecific intrauterine immunopotentiation, Toxicol. Methods, 5, 131, 1995.
69. Szabo, K.T. and Brent, R.L., Reduction of drug-induced cleft palate in mice, Lancet, 1, 1296, 1975.
70. Hemm, R.D., Arslanoglou, L., and Pollock, J.J., Cleft palate following prenatal food restriction in mice: association with elevated maternal corticosteroids, Teratology, 15, 243, 1977.
71. Ellington, S., In-vivo and in-vitro studies on the effects of maternal fasting during embryonic organ-ogenesis in the rat, J. Repro. Fertil., 60, 383, 1980.
72. Ikemi, N., Imada, J., Goto, T., Shimazu, H., and Yasuda, M., Effects of food restriction on the fetal development during major organogenesis in rats, Cong. Anom., 33, 363, 1993.
73. Petrere, J.A., Rohn, W.R., Grantham II, L.E., and Anderson, J.A., Food restriction during organogen-esis in rabbits: effects on reproduction and the offspring, Fundam. Appl. Toxicol., 21, 517, 1993.
74. Matsuzawa, T., Nakata, M., Goto, I., and Tsushima, M., Dietary deprivation induces fetal loss and abortions in rabbits, Toxicology, 22, 255, 1981.
75. Clark, R.L., Robertson, R.T., Peter, C.P., Bland, J.A., Nolan, T.E., Oppenheimer, L., and Bokelman, D.L., Association between adverse maternal and embryo/fetal effects in norfloxacin-treated and food-deprived rabbits, Fundam. Appl. Toxicol., 7, 272, 1986.
76. James, W.H., Evidence that mammalian sex ratios at birth are partially controlled by parental hormone levels at the time of conception, J. Theor. Biol., 180, 271, 1996.
77. James, W.H., Exposure to chemicals, offspring sex ratios, and their relevance to teratology [letter], Teratology, 62, 75, 2000.
78. Menegola, E., Broccia, M.L., Di Renzo, F., and Giavini, E., Comparative study of sodium valproate-induced skeletal malformations using single or double staining methods, Reprod. Toxicol., 16, 815, 2002.
79. Sucheston, M.E., Hayes, T.G., and Eluma, F.O., Relationship between ossification and body weight of the CD-1 mouse fetus exposed in utero to anticonvulsant drugs, Terat. Carcinog. Mutagen, 6, 537, 1986.
80. Wise, L.D., Beck, S.L., Beltrame, D., Beyer, B.K., Chahoud, I., Clark, R.L., Clark, R., Druga, A.M., Feuston, M.H., Guittin, P., Henwood, S.M., Kimmel, C.A., Lindstrom, P., Palmer, A.K., Petrere, J.A., Solomon, H.M., Yasuda, M., and York, R.G., Terminology of developmental abnormalities in common laboratory animals, Teratology, 55, 249, 1997.
81. Wilson, J.G., Embryological considerations in teratology. In Teratology: Principles and Techniques; Wilson, J.G. and Warkany, J., Eds., The University of Chicago Press, Chicago, 1965, p. 251.
82. Stuckhardt, J.L. and Poppe, S.M., Fresh visceral examination of rat and rabbit fetuses used in teratogenicity testing, Terat., Carcin. Mutagen., 4, 181, 1984.
83. Staples, R.E., Detection of visceral alterations in mammalian species [abstract], Teratology, 9, 37, 1974.
84. Barrow, M.V. and Taylor, W.J., A rapid method for detecting malformations in rat fetuses, J. Morphol., 127, 291, 1969.
85. Sawin, P. and Crary, D., Morphogenetic studies of the rabbit. X. Racial variations in the gall bladder, Anat. Rec., 110, 573, 1951.
86. Pitt, J.A., Snyder, L.T., Smith, B.L., Varsho, B.J., Nemec, M.D., and Holson, J.F., An x-ray study of the incidence of supernumary ribs and presacral vertebrae in adults rats, mice and rabbits, Teratology, 65, 328, 2002.
87. Chernoff, N., Rogers, J.M., Turner, C.I., and Francis, B.M., Significance of supernumerary ribs in rodent developmental toxicity studies: postnatal persistence in rats and mice, Fundam. Appl. Toxicol., 17, 448, 1991.
88. Foulon, O., Girard, H., Pallen, C., Urtizberea, M., Repetto-Larsay, M., and Blacker, A.M., Induction of supernumerary ribs with sodium salicylate, Reprod. Toxicol, 13, 369, 1999.
89. Wickramaratne, G.A. de S., The post-natal fate of supernumerary ribs in rat teratogenicity studies, J. Appl. Toxicol., 8, 91, 1988.
90. Foulon, O., Jaussely, C., Repetto, M., Urtizberea, M., and Blacker, A.M., Postnatal evolution of supernumerary ribs in rats after a single administration of sodium salicylate, J. Appl. Toxicol., 20, 205, 2000.
91. Green, E.L., The inheritance of a rib variation in the rabbit, Anat. Rec., 74, 47, 1939.
92. Greenaway, J.G., Partlow, G.D., Gonsholt, N.L., and Fisher, R.S., Anatomy of the lumbosacral spinal cord in rabbits, J. Amer. Animal Hosp. Assoc., 37, 27, 2001.
93. Beck, S.L., Assessment of adult skeletons to detect prenatal exposure to trypan blue in mice, Teratology, 28, 271, 1983.
94. Moore, K. and Persaud, T., Eds., The Developing Human: Clinically Oriented Human Embryology, 6th ed., W.B. Saunders, Philadelphia, 1998, p. 414.
95. Holson, J.F., Kimmel, C.A., Hogue, C.I., and Carlo, G.L., Suitability of experimental studies for predicting hazards to human development, in Proceedings of the 1981 Annual Winter Meeting of the Toxicology Forum, Arlington, VA, 1981.
96. Holson, J.F., DeSesso, J., Jacobson, C., and Farr, C., Appropriate use of animal models in the assessment of risk during prenatal development: an illustration using inorganic arsenic, Teratology, 62, 51, 2000.
97. National Academy of Sciences, Evaluating Chemical and Other Agent Exposures for Reproductive and Developmental Toxicity, National Academy Press, Washington, DC, 2001.
98. Takayama, S., Akaike, M., Kawashima, K., Takahashi, M., and Kurokawa, Y., A collaborative study in Japan on optimal treatment period and parameters for detection of male fertility disorders induced by drugs in rats, J. Am. Coll. Toxicol., 14, 266, 1995.
99. Barton, H.A. and Andersen, M.E., Endocrine active compounds: from biology to dose response assessment, Crit. Rev. Toxicol., 28, 363, 1998.
100. Sterner, T.R. and Mattie D.R., Perchlorate literature review and summary: developmental effects, metabolism, receptor kinetics and pharmacological uses, NTIS Technical Report (NTIS/ADA367421), 1998.
101. Kato, M., Fukunishi, K., Ikegawa, S., Higuchi, H., Sato, M., Horimoto, M., and Ito, S., Overview of studies on rat sperm motion analysis using a Hamilton-Thorne Sperm Analyzer - collaborative working study, J. Toxicol. Sci., 26, 285, 2001.
102. Linder, R.E., Strader, L.F., Slott, V.L., and Suarez, J.D., Endpoints of spermatotoxicity in the rat after short duration exposures to fourteen reproductive toxicants, Repro. Toxicol., 6, 491, 1992.
103. O'Connor, J.C., Davis, L.G., Frame, S.R., and Cook, J.C., Evaluation of a Tier I screening battery for detecting endocrine-active compounds (EACs) using the positive controls testosterone, coumestrol, progesterone, and RU486, Toxicol. Sci., 54, 338, 2000.
104. Russell, L.D., Ettlin, R., Sinha Hikim, A.P., and Clegg, E.D., Histological and Histopathological Evaluation of the Testis, Cache River Press, Clearwater, FL, 1990.
105. Long, J.A. and Evans, H.M., The oestrous cycle in the rat and its associated phenomena, Mem. Univ. Calif., 6, 1, 1922.
106. Foster, P.M.D., Reproductive performance, in An Evaluation and Interpretation of Reproductive Endpoints for Human Health Risk Assessment, Daston, G. and Kimmel, C., Eds., International Life Sciences Institute, Washington, DC, 1998, p. 5.
107. NTP-CERHR Expert Panel Report on the Reproductive and Developmental Toxicity of 1-Bromopro-pane, National Toxicology Program (NTP), Center for the Evaluation of Risks to Human Reproduction (CERHR), 2002.
108. Horimoto, M., Takeuchi, K., Iijima, M., and Tachibana, M., Reproductive and developmental toxicity studies with amlodipine in rats and rabbits, Oyo Yakuri, 42, 167, 1991.
109. Zippelius, H.M. and Schleidt, W.M., Ultraschallante bei jungen Mausen [Ultrasounds in young mice], Naturwissenschaften, 43, 502, 1956.
110. Noirot, E. and Pye, D., Sound analysis of ultrasonic distress calls of mouse pups as a function of their age, Animal Behavior, 17, 340, 1969.
111. Nicholas, K.R. and Hartmann, P.E., The foetoplacental unit and the initiation of lactation in the rat, Aust. J. Biol. Sci., 34, 455, 1981.
112. Orbach, J., Spontaneous ejaculation in rat, Science, 134, 1072, 1961.
113. Kihlström, J.E., Diurnal variation in the spontaneous ejaculations of the male albino rat, Nature, 209, 513, 1966.
114. Beach, F.A., Variables affecting "spontaneous" seminal emission in rats, Physiol. Behav., 15(1), 91, 1975.
115. Orbach, J., Miller, M., Billimoria, A., and Solhkhah, N., Spontaneous seminal ejaculation and genital grooming in rats, Brain Res., 5, 520, 1967.
116. Gallavan, Jr., R.H., Holson, J.F., Stump, D.G., Knapp, J.F., and Reynolds, V.L., Interpreting the toxicologic significance of alterations in anogenital distance: potential for confounding effects of progeny body weights, Repro. Toxicol., 13, 383, 1999.
117. Clark, R.L., Endpoints of reproductive system development, in An Evaluation and Interpretation of Reproductive Endpoints for Human Health Risk Assessment, Daston, G. and Kimmel, C.A., Eds., International Life Sciences Institute, Washington, DC, 1998, p. 10.
118. Ashby, J. and Lefevre, P.A., The peripubertal male rat assay as an alternative to the Hershberger castrated male rat assay for the detection of anti-androgens, oestrogens and metabolic modulators, J. Appl. Toxicol., 20, 35, 2000.
119. Mocarelli, P., Gerthoux, P.M., Ferrari, E., Patterson, Jr., D.G., Kieszak, S.M., Brambilla, P., Vincoli, N., Signorini, S., Tramacere, P., Carreri, V., Sampson, E.J., Turner, W.E., and Needham, L.L., Paternal concentrations of dioxin and sex ratio of offspring, Lancet, 355(9218), 1838, 2000.
120. Ryan, J.J., Amirova, Z., and Carrier, G., Sex ratios of Russian pesticide producers exposed to dioxin, Environ. Health Persp., 110, A 699, 2002.
121. Schnorr, T.M., Lawson, C.C., Whelan, E.A., Dankovic, D.A., Deddens, J.A., Piacitelli, L.A., Reefhuis, J., Sweeney, M.H., Conally, L.B., and Fingerhut, M.A., Spontaneous abortion, sex ratio, and paternal occupational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin, Environ. Health Perspec., 109, 1127, 2001.
122. International Conference on Harmonisation (ICH), Tripartite Guideline on Detection of Toxicity to Reproduction for Medicinal Products, Fed. Regist., Section 4.1.2, September 22, 1994.
123. U.S. Environmental Protection Agency, Health Effects Test Guideline, Developmental Neurotoxicity Study, OPPTS 870.6300, August 1998.
124. Organization for Economic Cooperation and Development, Guideline for the testing of chemicals, Developmental Neurotoxicity Study, Proposal for a New Guideline 426, September 2003 Draft.
125. Bolon, B., Bucci, J.J., Warbritton, A.R., Chen, J.J., Mattison, P.R., and Heindel, J.J., Differential follicle counts as a screen for chemically-induced ovarian toxicity in mice: results from continuous breeding bioassays, Fundam. Appl. Toxicol., 39, 1, 1997.
126. Bucci, T.J., Bolon, B., Warbritton, A.R., Chen, J.J., and Heindel, J.J., Influence of sampling on the reproducibility of ovarian follicle counts in mouse toxicity studies, Reprod. Toxicol., 11, 689, 1997.
127. Holson, J.F., Interpretation of low-incidence findings in developmental and reproductive toxicity studies, presented at the 2002 Annual Winter Meeting of the Toxicology Forum, Washington, DC, 2002.
128. Cook, J.C., Jacobson, C.F., Gao, F., Tassinari, M.S., Hurtt, M.E., and DeSesso, J.M., Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits, Birth Defects Res. Part B Dev. Reprod. Toxicol., 68, 5, 2003.
129. Nisbet, I.C.T. and Karch, N.J., Chemical Hazards to Human Reproduction, Noyes Data Corp., Park Ridge, IL, 1983.
130. Hemminki, K. and Vineis, P., Extrapolation of the evidence on teratogenicity of chemicals between humans and experimental animals: chemicals other than drugs, Teratog. Carcinog. Mutagen., 5, 251, 1985.
131. Kimmel, C.A., Rees, D.C., and Francis, E.Z., Eds., Proceedings of the Workshop on the Qualitative and Quantitative Comparability of Human and Animal Developmental Neurotoxicity, Neurotoxicol. Teratol, 12, 173, 1990.
132. Newman, L.M., Johnson, E.M., and Staples, R.E., Assessment of the effectiveness of animal developmental toxicity testing for human safety, Reprod. Toxicol., 7, 359, 1993.
133. March of Dimes Birth Defects Foundation, 1996, Birth Defects and Infant Mortality: A National and Regional Profile, March of Dimes Birth Defects Foundation, New York.
134. Frohberg, H., Gleich, J., and Unkelbach, H.D., Reproduction toxicological studies on cefazedone, Arzneim. Forsch., 29, 419, 1979.
135. Duffy, J.Y., Overmann, G.J., Keen, C.L., and Daston, G.P., Cardiac abnormalities induced by zinc deficiency are associated with alterations in the expression of genes regulated by zinc-finger transcription factors, Teratology, 59, 382, 1999.
136. Stump, D.G., Holson, J.F., Kirkpatrick, D.T., Reynolds, V.L., Siddiqui, W.H., and Meeks, R.G., Evaluation of octamethylcyclotetrasiloxane (D4) in a 2-generation reproductive toxicity study in rats, The Toxicologist 54, 370, 2000.
137. Youreneff, M.A., Singh, A.R., Hazelette, J.R., Yau, E.T., and Traina, V.M., Teratogenic evaluation of benazepril hydrochloride in mice, rats, and rabbits, J. Am. Coll. Toxicol., 9, 647, 1990.
138. 1-selective angiotensin II receptor antagonist Losartan in rats, Teratology, 51, 367, 1995.
139. 1-selective angiotensin II receptor antagonist Losartan in rats, Teratology, 51, 383, 1995.
140. Sweeney, L.M., Tyler, T.R., Kirman, C.R., Corley, R.A., Reitz, R.H., Paustenbach, D.J., Holson, J.F., Whorton, M.D., Thompson, K.M., and Gargas, M.L., Proposed occupational exposure limits for select ethylene glycol ethers using PBPK models and Monte Carlo simulations, Toxicol. Sci., 62, 124, 2001.
141. Terry, K.K., Elswick, B.A., Stedman, D.B., and Welsch, F., Developmental phase alters dosimetry-teratogenicity relationship for 2-methoxyethanol in CD-1 Mice, Teratology, 49, 218, 1994.
142. Clarke, D.O., Elswick, B.A., Welsch, F., and Conolly, R.R., Pharmacokinetics of 2-methoxyethanol and 2-methoxyacetic acid in the pregnant mouse: a physiologically based mathematical model, Toxicol. Appl. Pharm., 121, 239, 1993.
143. Nau, H., Teratogenicity of isotretinoin revisited: species variation and the role of all-trans-retinoic acid, J. Am. Acad. Dermatol., 45, S183, 2001.
144. Tzimas, G., Thiel, R., Chahoud, I., and Nau, H., The area under the concentration-time curve of all-trans-retinoic acid is the most suitable pharmacokinetic correlate to the embryotoxicity of this retinoid in the rat, Toxicol. Appl. Pharm., 143, 436, 1997.
145. Collins, M.D., Tzimas, G., Hummler, H., Bürgin, H., and Nau, H., Comparative teratology and transplacental pharmacokinetics of all-trans-retinoic acid, 13-cis-retinoic acid, and retinyl palmitate following daily administration in rats, Toxicol. Appl. Pharm., 127, 132, 1994.
146. Nau, H., Embryotoxicity and teratogenicity of topical retinoic acid, Skin Pharmacol., 6(Suppl.1), 35, 1993.
147. U.S. Environmental Protection Agency, Standard Evaluation Procedure, Developmental Toxicity Studies, Health Effects Division, Office of Pesticides Programs, Washington, DC, 1993.
148. Arlitt, A.H., The effect of alcohol on the intelligent behavior of the white rat and its progeny, Psychol. Monogr., 26, 1, 1919.
149. Thiersch, J.B. and Phillips, F.S., Effect of 4-amino-pteroylglutamic acid (aminopterin) on early pregnancy, Proc. Soc. Exp. Biol. Med., 74, 204, 1950.
150. Shoeneck, F.J., Cigarette smoking in pregnant women, N.Y. State J. Med., 41, 1945, 1941.
151. Greene, R.R., Burrill, M.W., and Ivy, A.C., Experimental intersexuality. The effects of estrogens on the antenatal sexual development of the rat, Am. J. Anat., 67, 305, 1940.
152. Geber, W.F. and Schramm, L.C., Comparative teratogenicity of morphine, heroin and methadone in the hamster, Pharmacologist, 11, 248, 1969.
153. Russell, L.B, X-ray induced developmental abnormalities in the mouse and their use in the analysis of embryological patterns, J. Exp. Zool., 114, 545, 1950.
154. Matsumoto, H., Koya, G., and Takeuchi, T., Fetal Minamata disease: A neuropathological study of two cases of intrauterine intoxication by methyl mercury compound, J. Neuropathol. Exp. Neurol., 24, 563, 1965.
155. Taki, I., Hisanaga, S., and Amagase, Y., Report on Yusno (chlorobiphenyls poisoning). Pregnant women and their fetuses, Fukuoka Acta Med., 60, 471, 1969.
156. van Wagenen, G. and Hamilton, J.B., The experimental production of pseudohermaphroditism in the monkey, Essays Biol., 583, 1943.
157. Lenz, W., Kindliche Missbildungen nach Medikament wahrend der Draviditat?, Dtsch. Med. Wochen-schr., 86, 2555, 1961.
158. McBride, W.G., Thalidomide and congenital abnormalities, Lancet, 2, 1358, 1961.
159. Holson, J.F., Estimation and extrapolation of teratologic risk, in Proceedings of NATO Conference on in vitro Toxicity Testing of Environmental Agents: Current and Future Possibilities, NATO, Monte Carlo, Monaco, 1980.
160. Brown, N.A. and Fabro, S.F., The value of animal teratogenicity testing for predicting human risk, Clin. Obstet. Gynecol., 26(2), 467, 1983.
161. Buelke-Sam, J. and Mactutus, C., Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity: testing methods in developmental neurotoxicity for use in human risk assessment, Neurotoxicol. Teratol., 12, 269, 1990.
162. Shepard, T.H., Catalog of Teratogenic Agents, 8th ed., The Johns Hopkins University Press, Baltimore, 1995.
163. Schardein, J.L., Chemically Induced Birth Defects, 3rd ed., Marcel Dekker, New York, 2000.
164. Barlow, S.M. and Sullivan, F.M., Reproductive Hazards of Industrial Chemicals, Academic Press, London, 1982.
165. U.S. Congress, Office of Technology Assessment, Reproductive Health Hazards in the Workplace, OTA-BA-266, U.S. Government Printing Office, Washington, DC, 1985, p. 161.
166. U.S. Environmental Protection Agency, Health Effects Test Guidelines: Prenatal Developmental Toxicity Study, Office of Prevention, Pesticides and Toxic Substances (OPPTS) 870.3700, 1998.
167. U.S. Food and Drug Administration, International Conference on Harmonisation; Guideline on detection of toxicity to reproduction for medicinal products. Fed. Regist., 59(No. 183), 1994.
168. Organization for Economic Cooperation and Development, Guidelines for Testing of Chemicals. Section 4, No. 414: Teratogenicity, adopted 22 January 2001.
169. U.S. Food and Drug Administration, Office of Food Additive Safety, IV.C.9.b., Guidelines for developmental toxicity studies, Redbook 2000-Toxicological Principles for the Safety Assessment of Food Ingredients, College Park, MD, 2000.
170. U.S. Food and Drug Administration, Guidance for Industry-Considerations for Reproductive Toxicity Studies for Preventive Vaccines for Infectious Disease Indications, Rockville, MD, 2000 (Draft).
171. Japanese Ministry of Agriculture, Forestry and Fisheries (MAFF), Developmental Toxicity Testing Guidelines, 1985.
172. U.S. Food and Drug Administration, Office of Food Additive Safety, IV.C.9.a., Guidelines for reproduction studies, Redbook 2000-Toxicological Principles for the Safety Assessment of Food Ingredients, College Park, MD, 2000.
173. OECD, OECD Guideline for Testing of Chemicals, Proposal for Updating Guideline 416, Two-Generation Reproduction Study, OECD, Paris, France, 2001.
174. U.S. Environmental Protection Agency, Health Effects Test Guidelines; Reproduction and Fertility Effects, Office of Prevention, Pesticides and Toxic Substances (OPPTS) 870.3800, 1998b.
175. ICH Expert Working Group, ICH Harmonised Tripartite Guideline, Detection of Toxicity to Reproduction for Medicinal Products, S5A, International Conference on Harmonisation, Geneva, Switzerland, 1994.
176. ICH Expert Working Group, Maintenance of the ICH Guidelines on Toxicity to Male Fertility, an Addendum to the ICH Harmonised Tripartite guideline, Detection of Toxicity to Reproduction for Medicinal Products, S5B(M), International Conference on Harmonisation, Geneva, Switzerland, 1994.